To validate this hypothesis, an enzyme‐linked immunosorbent assay (ELISA) assay was conducted to quantify the VEGFA levels in conditioned medium derived from breast cancer cells with either GLO1 knockdown or overexpression. The gene discussed is GLO1; the disease is breast carcinoma.